{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:54:10Z","timestamp":1793332450177,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05365-y","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T07:37:03Z","timestamp":1744875423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of low-dose primaquine treatment on Plasmodium vivax recurrence and transmission-blocking activity in southwest Ethiopia: a longitudinal cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Hallelujah","family":"Getachew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassahun","family":"Habtamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashenafi","family":"Abossie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assalif","family":"Demissew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arega","family":"Tsegaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teshome","family":"Degefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daibin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofa","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MingChieh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Kazura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delenasaw","family":"Yewhalaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"5365_CR1","volume-title":"World malaria report 2023","author":"WHO","year":"2023","unstructured":"WHO. World malaria report 2023. Geneva: World Health Organization; 2023."},{"key":"5365_CR2","unstructured":"Federal Democratic Republic of Ethiopia Ministry of Health. National Malaria Guidelines, 4th Edn. Addis Ababa; 2017."},{"key":"5365_CR3","doi-asserted-by":"publisher","first-page":"a025585","DOI":"10.1101\/cshperspect.a025585","volume":"7","author":"JH Adams","year":"2017","unstructured":"Adams JH, Mueller I. The biology of Plasmodium vivax. Cold Spring Harb Perspect Med. 2017;7:a025585.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5365_CR4","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1128\/AAC.00186-16","volume":"60","author":"L Zuluaga-Id\u00e1rraga","year":"2016","unstructured":"Zuluaga-Id\u00e1rraga L, Blair S, Okoth SA, Udhayakumar V, Marcet PL, Escalante AA, et al. Prospective study of Plasmodium vivax malaria recurrence after radical treatment with a chloroquine-primaquine standard regimen in Turbo, Colombia. Antimicrob Agents Chemother. 2016;60:4610\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"5365_CR5","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1086\/424663","volume":"39","author":"JK Baird","year":"2004","unstructured":"Baird JK, Hoffman SL. Primaquine therapy for malaria. Clin Infect Dis. 2004;39:1336\u201345.","journal-title":"Clin Infect Dis"},{"key":"5365_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-12-397900-1.00002-5","volume":"80","author":"NJ White","year":"2012","unstructured":"White NJ, Imwong M. Relapse. Adv Parasitol. 2012;80:113\u201344.","journal-title":"Adv Parasitol"},{"key":"5365_CR7","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2015","unstructured":"WHO. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015.","edition":"3"},{"key":"5365_CR8","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S1473-3099(18)30348-7","volume":"18","author":"RJ Commons","year":"2018","unstructured":"Commons RJ, Simpson JA, Thriemer K, Humphreys GS, Abreha T, Alemu SG, et al. The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis. Lancet Infect Dis. 2018;18:1025\u201334.","journal-title":"Lancet Infect Dis"},{"key":"5365_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1756-3305-4-46","volume":"4","author":"T Ketema","year":"2011","unstructured":"Ketema T, Getahun K, Bacha K. Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Halaba district, South Ethiopia. Parasit Vectors. 2011;4:46.","journal-title":"Parasit Vectors"},{"key":"5365_CR10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12936-015-1041-4","volume":"14","author":"S Getachew","year":"2015","unstructured":"Getachew S, Thriemer K, Auburn S, Abera A, Gadisa E, Aseffa A, et al. Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia. Malar J. 2015;14:525.","journal-title":"Malar J"},{"key":"5365_CR11","doi-asserted-by":"publisher","first-page":"e0011425","DOI":"10.1371\/journal.pntd.0011425","volume":"17","author":"AO Andrade","year":"2023","unstructured":"Andrade AO, Santos NAC, Bastos AS, Pontual JDC, Ara\u00fajo JE, Silva AMV, et al. Transmission-blocking activity of antimalarials for Plasmodium vivax malaria in Anopheles darlingi. PLoS Negl Trop Dis. 2023;17:e0011425.","journal-title":"PLoS Negl Trop Dis"},{"key":"5365_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/B978-0-12-397900-1.00005-0","volume":"80","author":"NM Douglas","year":"2012","unstructured":"Douglas NM, John GK, von Seidlein L, Anstey NM, Price RN. Chemotherapeutic strategies for reducing transmission of Plasmodium vivax malaria. Adv Parasitol. 2012;80:271\u2013300.","journal-title":"Adv Parasitol"},{"key":"5365_CR13","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1038\/srep03418","volume":"3","author":"WJR Stone","year":"2013","unstructured":"Stone WJR, Eldering M, Van Gemert GJ, Lanke KHW, Grignard L, Van De Vegte-Bolmer MG, et al. The relevance and applicability of oocyst prevalence as a read-out for mosquito feeding assays. Sci Rep. 2013;3:3418.","journal-title":"Sci Rep"},{"key":"5365_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12936-019-2777-z","volume":"18","author":"D Hawaria","year":"2019","unstructured":"Hawaria D, Getachew H, Zhong G, Demissew A, Habitamu K, Raya B, et al. Ten years malaria trend at Arjo-Didessa sugar development site and its vicinity, Southwest Ethiopia: a retrospective study. Malar J. 2019;18:145.","journal-title":"Malar J"},{"key":"5365_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12936-023-04762-5","volume":"22","author":"H Getachew","year":"2023","unstructured":"Getachew H, Demissew A, Abossie A, Habtamu K, Wang X, Zhong D, et al. Asymptomatic and submicroscopic malaria infections in sugar cane and rice development areas of Ethiopia. Malar J. 2023;22:341.","journal-title":"Malar J"},{"key":"5365_CR16","unstructured":"Federal Democratic Republic of Ethiopia Ministry of Health. Malaria Elimination Roadmap in Ethiopia. Addis Ababa, Ethiopia; 2017."},{"key":"5365_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.actatropica.2009.10.001","volume":"113","author":"AK Yeshiwondim","year":"2010","unstructured":"Yeshiwondim AK, Tekle AH, Dengela DO, Yohannes AM, Teklehaimanot A. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia. Acta Trop. 2010;113:105\u201313.","journal-title":"Acta Trop"},{"key":"5365_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0166-6851(93)90077-B","volume":"61","author":"G Snounou","year":"1993","unstructured":"Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol. 1993;61:315\u201320.","journal-title":"Mol Biochem Parasitol"},{"key":"5365_CR19","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1128\/JCM.01858-08","volume":"47","author":"SE Shokoples","year":"2009","unstructured":"Shokoples SE, Ndao M, Kowalewska-Grochowska K, Yanow SK. Multiplexed real-time PCR assay for discrimination of Plasmodium species with improved sensitivity for mixed infections. J Clin Microbiol. 2009;47:975\u201380.","journal-title":"J Clin Microbiol"},{"key":"5365_CR20","first-page":"16","volume":"4","author":"AL Ou\u00e9draogo","year":"2013","unstructured":"Ou\u00e9draogo AL, Guelb\u00e9ogo WM, Cohuet A, Morlais I, King JG, Gon\u00e7alves BP, et al. A protocol for membrane feeding assays to determine the infectiousness of P. falciparum naturally infected individuals to Anopheles gambiae. MalarWorld J. 2013;4:16.","journal-title":"MalarWorld J"},{"key":"5365_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1017\/S0031182000076721","volume":"106","author":"GF Medley","year":"1993","unstructured":"Medley GF, Sindent RE, Fleck S, Billingsley PF, Tirawanchai N, Rodriguez MH. Heterogeneity in patterns of malarial oocyst infections in the mosquito vector. Parasitology. 1993;106:441\u20139.","journal-title":"Parasitology"},{"key":"5365_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1385\/1-59259-271-6:189","volume-title":"Malaria methods and protocols","author":"G Snounou","year":"2002","unstructured":"Snounou G, Singh B. Nested PCR analysis of Plasmodium parasites. In: Doolan DL, editor. Malaria methods and protocols. Totowa: Humana Press, Inc; 2002. p. 189\u2013203."},{"key":"5365_CR23","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.exppara.2008.12.012","volume":"121","author":"V Veron","year":"2009","unstructured":"Veron V, Simon S, Carme B. Multiplex real-time PCR detection of P. falciparum, P. vivax and P. malariae in human blood samples. Exp Parasitol. 2009;121:346\u201351.","journal-title":"Exp Parasitol"},{"key":"5365_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12936-025-05279-9","volume":"24","author":"K Habtamu","year":"2025","unstructured":"Habtamu K, Getachew H, Abossie A, Demissew A, Tsegaye A, King CL, et al. Post-treatment transmissibility of Plasmodium falciparum infections: an observational cohort study. Malar J. 2025;24:87.","journal-title":"Malar J"},{"key":"5365_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12936-021-03725-y","volume":"20","author":"HM Soumare","year":"2021","unstructured":"Soumare HM, Guelbeogo WM, van de Vegte-Bolmer M, van Gemert GJ, Soumanaba Z, Ouedraogo A, et al. Maintaining Plasmodium falciparum gametocyte infectivity during blood collection and transport for mosquito feeding assays in the field. Malar J. 2021;20:191.","journal-title":"Malar J"},{"key":"5365_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/ije\/dyu222","volume":"44","author":"LDAF Amorim","year":"2015","unstructured":"Amorim LDAF, Cai J. Modelling recurrent events: a tutorial for analysis in epidemiology. Int J Epidemiol. 2015;44:324\u201333.","journal-title":"Int J Epidemiol"},{"key":"5365_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cegh.2019.01.013","volume":"7","author":"M Thenmozhi","year":"2019","unstructured":"Thenmozhi M, Jeyaseelan V, Jeyaseelan L, Isaac R. Survival analysis in longitudinal studies for recurrent events: applications and challenges. Clin Epidemiol Glob Health. 2019;7:253\u201360.","journal-title":"Clin Epidemiol Glob Health"},{"key":"5365_CR28","doi-asserted-by":"publisher","first-page":"e1002677","DOI":"10.1371\/journal.pmed.1002677","volume":"15","author":"T Abreha","year":"2018","unstructured":"Abreha T, Hwang J, Thriemer K, Tadesse Y, Girma S, Melaku Z, et al. Correction: Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: a randomized controlled trial. PLoS Med. 2018;15:e1002677.","journal-title":"PLoS Med"},{"key":"5365_CR29","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12936-023-04725-w","volume":"22","author":"P Mehdipour","year":"2023","unstructured":"Mehdipour P, Rajasekhar M, Dini S, Zaloumis S, Abreha T, Adam I, et al. Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis. Malar J. 2023;22:306.","journal-title":"Malar J"},{"key":"5365_CR30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12936-024-05031-9","volume":"23","author":"H Gebrie","year":"2024","unstructured":"Gebrie H, Yimer M, Ayehu A, Mohammed H, Hailgiorgis H, Wuletaw Y. Efficacy and safety of chloroquine plus primaquine for the treatment of Plasmodium vivax malaria in Hamusit site, Northwestern Ethiopia. Malar J. 2024;23:202.","journal-title":"Malar J"},{"key":"5365_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12936-023-04562-x","volume":"22","author":"DA Mekonnen","year":"2023","unstructured":"Mekonnen DA, Abadura GS, Behaksra SW, Taffese HS, Bayissa GA, Bulto MG, et al. Treatment of uncomplicated Plasmodium vivax with chloroquine plus radical cure with primaquine without G6PDd testing is safe in Arba Minch, Ethiopia: assessment of clinical and parasitological response. Malar J. 2023;22:135.","journal-title":"Malar J"},{"key":"5365_CR32","doi-asserted-by":"publisher","first-page":"e63433","DOI":"10.1371\/journal.pone.0063433","volume":"8","author":"J Hwang","year":"2013","unstructured":"Hwang J, Alemayehu BH, Reithinger R, Tekleyohannes G, Teshi T, Birhanu SG, et al. In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax\u202f: a randomized open label trial in Central Ethiopia. PLoS ONE. 2013;8:e63433.","journal-title":"PLoS ONE"},{"key":"5365_CR33","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/1475-2875-9-308","volume":"9","author":"R Takeuchi","year":"2010","unstructured":"Takeuchi R, Lawpoolsri S, Imwong M, Kobayashi J, Kaewkungwal J, Pukrittayakamee S, et al. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border. Malar J. 2010;9:308.","journal-title":"Malar J"},{"key":"5365_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4269\/ajtmh.2001.65.471","volume":"65","author":"EC Duarte","year":"2001","unstructured":"Duarte EC, Pang LW, Ribeiro LC, Fernandes Fontes CJ. Association of subtherapeutic dosages of a standard drug regimen with failures in preventing relapses of vivax malaria. Am J Trop Med Hyg. 2001;65:471\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"5365_CR35","doi-asserted-by":"publisher","first-page":"e1002379","DOI":"10.1371\/journal.pmed.1002379","volume":"14","author":"NM Douglas","year":"2017","unstructured":"Douglas NM, Poespoprodjo JR, Patriani D, Malloy MJ, Kenangalem E, Sugiarto P, et al. Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: a hospital-based cohort study. PLoS Med. 2017;14:e1002379.","journal-title":"PLoS Med"},{"key":"5365_CR36","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.4269\/ajtmh.17-0290","volume":"97","author":"GR Awab","year":"2017","unstructured":"Awab GR, Imwong M, Bancone G, Jeeyapant A, Day NPJ, White NJ, et al. Chloroquine-primaquine versus chloroquine alone to treat vivax malaria in Afghanistan: an open randomized superiority trial. Am J Trop Med Hyg. 2017;97:1782\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"5365_CR37","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/cid\/ciy319","volume":"67","author":"CS Chu","year":"2018","unstructured":"Chu CS, Phyo AP, Lwin KM, Win HH, San T, Aung AA, et al. Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in Plasmodium vivax malaria. Clin Infect Dis. 2018;67:1543\u20139.","journal-title":"Clin Infect Dis"},{"key":"5365_CR38","volume-title":"Monitoring antimalarial drug resistance: report of a WHO consultation","author":"WHO","year":"2002","unstructured":"WHO. Monitoring antimalarial drug resistance: report of a WHO consultation. Geneva: World Health Organization; 2002."},{"key":"5365_CR39","volume-title":"Methods for surveillance of antimalarial drug efficacy","author":"WHO","year":"2009","unstructured":"WHO. Methods for surveillance of antimalarial drug efficacy. Geneva: World Health Organization; 2009."},{"key":"5365_CR40","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3201\/eid2408.170768","volume":"24","author":"J Popovici","year":"2018","unstructured":"Popovici J, Vantaux A, Primault L, Samreth R, Piv EP, Bin S, et al. Therapeutic and transmission-blocking efficacy of dihydroartemisinin\/piperaquine and chloroquine against Plasmodium vivax malaria. Cambodia Emerg Infect Dis. 2018;24:1516\u20139.","journal-title":"Cambodia Emerg Infect Dis"},{"key":"5365_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4269\/ajtmh.1958.7.207","volume":"7","author":"GM Jeffery","year":"1958","unstructured":"Jeffery GM. Infectivity to mosquitoes of Plasmodium vivax following treatment with chloroquine and other antimalarials. Am J Trop Med Hyg. 1958;7:207\u201311.","journal-title":"Am J Trop Med Hyg"},{"key":"5365_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4269\/ajtmh.1991.45.471","volume":"45","author":"TA Klein","year":"1991","unstructured":"Klein TA, Tada MS, Lima JHP, Katsuragawa TH. Infection of Anopheles darlingi fed on patients infected with Plasmodium vivax before and during treatment with chloroquine in Costa Marques, Rondonia, Brazil. Am J Trop Med Hyg. 1991;45:471\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"5365_CR43","doi-asserted-by":"publisher","first-page":"e0085324","DOI":"10.1128\/aac.00853-24","volume":"68","author":"V Chaumeau","year":"2024","unstructured":"Chaumeau V, Wasisakun P, Watson JA, Oo T, Aryalamloed S, Sue MP, et al. Transmission-blocking activities of artesunate, chloroquine, and methylene blue on Plasmodium vivax gametocytes. Antimicrob Agents Chemother. 2024;68:e0085324.","journal-title":"Antimicrob Agents Chemother"},{"key":"5365_CR44","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1590\/0102-311X00169312","volume":"30","author":"LR Sim\u00f5es","year":"2014","unstructured":"Sim\u00f5es LR, Alves ER, Ribatski-Silva D, Gomes LT, Nery AF, Fontes CJF. Factors associated with recurrent Plasmodium vivax malaria in Porto Velho, Rond\u00f4nia state, Brazil, 2009. Cad Saude Publica. 2014;30:1403\u201317.","journal-title":"Cad Saude Publica"},{"key":"5365_CR45","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/infdis\/jit261","volume":"208","author":"NM Douglas","year":"2013","unstructured":"Douglas NM, Simpson JA, Phyo AP, Siswantoro H, Hasugian AR, Kenangalem E, et al. Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivax. J Infect Dis. 2013;208:801\u201312.","journal-title":"J Infect Dis"},{"key":"5365_CR46","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4269\/ajtmh.2008.79.378","volume":"79","author":"S Pukrittayakamee","year":"2008","unstructured":"Pukrittayakamee S, Imwong M, Singhasivanon P, Stepniewska K, Day NJ, White NJ. Effects of different antimalarial drugs on gametocyte carriage in P. vivax malaria. Am J Trop Med Hyg. 2008;79:378\u201384.","journal-title":"Am J Trop Med Hyg"},{"key":"5365_CR47","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4269\/ajtmh.1986.35.275","volume":"5","author":"MR Hollingdale","year":"1986","unstructured":"Hollingdale MR, Collins WE, Campbell CC. In vitro culture of exoerythrocytic parasites of the North Korean strain of Plasmodium vivax in hepatoma cells. Am J Trop Med Hyg. 1986;5:275\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"5365_CR48","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1475-2875-10-297","volume":"10","author":"NJ White","year":"2011","unstructured":"White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10:297.","journal-title":"Malar J"},{"key":"5365_CR49","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/0035-9203(76)90133-4","volume":"70","author":"E Ungureanu","year":"1976","unstructured":"Ungureanu E, Killick-Kendrick R, Garnham P, Branzei P, Romanescu C, Shute P. Prepatent periods of a tropical strain of Plasmodium vivax after inoculations of tenfold dilutions of sporozoites. Trans R Soc Trop Med Hyg. 1976;70:482\u20133.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5365_CR50","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12936-019-2644-y","volume":"18","author":"A Daher","year":"2019","unstructured":"Daher A, Silva JCAL, Stevens A, Marchesini P, Fontes CJ, Ter Kuile FO, et al. Evaluation of Plasmodium vivax malaria recurrence in Brazil. Malar J. 2019;18:18.","journal-title":"Malar J"},{"key":"5365_CR51","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12936-019-2763-5","volume":"18","author":"S Lawpoolsri","year":"2019","unstructured":"Lawpoolsri S, Sattabongkot J, Sirichaisinthop J, Cui L, Kiattibutr K, Rachaphaew N, et al. Epidemiological profile of recurrent malaria episodes in an endemic area along the Thailand-Myanmar border: a prospective cohort study. Malar J. 2019;18:124.","journal-title":"Malar J"},{"key":"5365_CR52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13071-020-04205-z","volume":"13","author":"JR Davidson","year":"2020","unstructured":"Davidson JR, Baskin RN, Hasan H, Burton TA, Wardiman M, Rahma N, et al. Characterization of vector communities and biting behavior in South Sulawesi with host decoy traps and human landing catches. Parasit Vectors. 2020;13:329.","journal-title":"Parasit Vectors"},{"key":"5365_CR53","volume-title":"Anopheles mosquitoes -New insights into malaria vectors","author":"W Suwonkerd","year":"2013","unstructured":"Suwonkerd W, Ritthison W, Ngo CT, Tainchum K, Bangs MJ, Theeraphap C. Vector biology and malaria transmission in Southeast Asia. In: Manguin S, editor. Anopheles mosquitoes -New insights into malaria vectors. IntechOpen; 2013."},{"key":"5365_CR54","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1365-3156.2004.01378.x","volume":"10","author":"DT Ho","year":"2005","unstructured":"Ho DT, Van Bortel W, Sochantha T, Keokenchanh K, Bri\u00ebt OJT, Coosemans M. Behavioural heterogeneity of Anopheles species in ecologically different localities in Southeast Asia: a challenge for vector control. Trop Med Int Health. 2005;10:251\u201362.","journal-title":"Trop Med Int Health"},{"key":"5365_CR55","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/1475-2875-12-364","volume":"12","author":"FM Smithuis","year":"2013","unstructured":"Smithuis FM, Kyaw MK, Phe UO, Van Der Broek I, Katterman N, Rogers C, et al. Entomological determinants of insecticide-treated bed net effectiveness in Western Myanmar. Malar J. 2013;12:364.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05365-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05365-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05365-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T10:03:01Z","timestamp":1746612181000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05365-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5365"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05365-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}